Estandarización de alérgenos utilizando lectinas.

Same author

Sugammadex and hypersensitivity.

Anaesthesia and intensive care·2014

Same author

Sugammadex and anaphylaxis in the operating theater.

Revista espanola de anestesiologia y reanimacion·2014

Same author

Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012

Same author

The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?

Mini reviews in medicinal chemistry·2012

Same author

Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.

Anaesthesia and intensive care·2012

Same author

Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Estandarización de alérgenos utilizando lectinas.

Videos de Conceptos Relacionados

Sugammadex and hypersensitivity.

Sugammadex and anaphylaxis in the operating theater.

Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response?

The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?

Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.

Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Videos de Experimentos Relacionados

Estandarización de alérgenos utilizando lectinas.

Videos de Conceptos Relacionados

Artículos Relacionados

Sugammadex and hypersensitivity.

Sugammadex and anaphylaxis in the operating theater.

Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response?

The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?

Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.

Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.